Evidence map›Paper›PMID 33101271›Full record

ArticleFrontiers in immunology2020

Memory-Like Responses of Brain Microglia Are Controlled by Developmental State and Pathogen Dose.

Trim Lajqi, Milan Stojiljkovic, David L Williams, Hannes Hudalla, Michael Bauer, Otto W Witte, Reinhard Wetzker, Reinhard Bauer, Christian Schmeer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Maladaptive trained immunity in viral infections.The Journal of clinical investigation · 2025
    Review
  10. Review
  11. Article
  12. JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Trim LajqiInstitute of Molecular Cell Biology, Jena University Hospital, Jena, Germany.
Milan StojiljkovicHans-Berger Department of Neurology, Jena University Hospital, Jena, Germany.
David L WilliamsDepartment of Surgery and Center of Excellence in Inflammation, Infectious Disease and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
Hannes HudallaDepartment of Neonatology, Heidelberg University Children's Hospital, Heidelberg, Germany.
Michael BauerDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Otto W WitteHans-Berger Department of Neurology, Jena University Hospital, Jena, Germany.
Reinhard WetzkerDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Reinhard BauerInstitute of Molecular Cell Biology, Jena University Hospital, Jena, Germany.
Christian SchmeerHans-Berger Department of Neurology, Jena University Hospital, Jena, Germany.
Jena University Hospital · DEEast Tennessee State University · USHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia, the innate immune cells of the central nervous system, feature adaptive immune memory with implications for brain homeostasis and pathologies. However, factors involved in the emergence and regulation of these opposing responses in microglia have not been fully addressed. Recently, we showed that microglia from the newborn brain display features of trained immunity and immune tolerance after repeated contact with pathogens in a dose-dependent manner. Here, we evaluate the impact of developmental stage on adaptive immune responses of brain microglia after repeated challenge with ultra-low (1 fg/ml) and high (100 ng/ml) doses of the endotoxin LPS

Indexed as

Immunologic MemoryAge FactorsAnimalsBiomarkersBrainBrain-Derived Neurotrophic FactorCell SurvivalCytokinesEnergy MetabolismHost-Pathogen InteractionsLactic AcidLipopolysaccharidesMaleMiceMicrogliaNitric Oxide Synthase Type IIBiomarkersBrain-Derived Neurotrophic FactorCytokinesLactic AcidLipopolysaccharidesNitric Oxide Synthase Type IIReactive Oxygen SpeciesLPSmaturationmicrogliatolerancetrained immunityβ-glucan

Identifiers

PMID33101271
PMCPMC7546897
OpenAlexW3088522006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.